Pulmonology
Commentary
COVID can mimic prostate cancer symptoms
“I had none of those previously reported experiences that could suddenly trigger a spike in PSA.”
From the Journals
Depression tied to inflammation and survival in lung cancer
A new study’s findings underscore the importance of assessing and treating depression in patients with cancer, particularly given the high rate of...
Commentary
What’s the ‘secret sauce’ to help patients move more?
When surveyed about aerobic exercise and strength training, only 24.6% meet weekly recommendations.
Feature
Liquid albuterol shortage effects reduced by alternative drugs, similar shortages may be increasingly common
The shortage of 0.5% albuterol sulfate inhalation solution gained increased attention earlier this month when Akorn Pharmaceuticals – one of just...
From the Journals
Brain imaging markers of breathlessness-expectation predict COPD rehabilitation success
D-cycloserine was associated with breathlessness improvement.
Feature
NOVIDs: Do some have the genes to dodge COVID?
Some in the U.S. have apparently managed to avoid the virus, data suggest.
From the Journals
Factors linked with increased VTE risk in COVID outpatients
While the overall risk for VTE was low, age of at least 55 years, being male, and having a BMI of at least 30 and history of VTE increased the...
From the Journals
Adherence to DASH diet reduced risk of COPD
Reduced risk of COPD with the DASH diet persistent in subgroups of men, younger adults, and smokers.
Conference Coverage
‘Unheard of’ PAH improvement with novel drug: STELLAR
Sotatercept, a designer molecule that removes a key driver of pulmonary arterial hypertension, had efficacy and safety in the first of three...
Commentary
A surfing PA leads an intense beach rescue
The rescue started with the PA beginning CPR on a man he found on the beach, who was blue in the face, had some secretions around his mouth, and...
Conference Coverage
FREEDOM COVID: Full-dose anticoagulation cut mortality but missed primary endpoint
In an in-hospital anticoagulation trial, the primary COVID endpoint was missed but a survival benefit is observed.